Recruiting Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340 Conditions Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more Locations University of Alabama_6th Ave — Birmingham, Alabama, United States Massachusetts General Hospital — Boston, Massachusetts, United States Dana Farber / Harvard Cancer Center — Boston, Massachusetts, United States Mayo Clinic - Rochester — Rochester, Minnesota, United States View all 52 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer NCT06394804 Conditions Low-grade Serous Ovarian Cancer Locations Emory Winship Cancer Institute — Atlanta, Georgia, United States Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth (Limited Protocol Activities) — Middletown, New Jersey, United States Memorial Sloan Kettering Bergen (Limited Protocol Activities) — Montvale, New Jersey, United States View more locations Show fewer locations Loading locations... View Trial Details
